FDA Inspection 1324524 — AIRGLE CORPORATION

AIRGLE CORPORATION — FEI 3030650766

The FDA completed an inspection of AIRGLE CORPORATION on Jun 30, 2026 in Holbrook, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 30, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Holbrook, NY (United States)

Citations

IDCFRDescription
23136ISO 13485:2016 Clause 7.3.10Design and development files not maintained
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.